Targeting Bacterial Metabolism with Natural and Synthetic Inhibitors

A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Medicinal Chemistry".

Deadline for manuscript submissions: 25 November 2025 | Viewed by 14

Special Issue Editors


E-Mail
Guest Editor
Microbiology Department, Faculty of Medicine, University of Medicine and Pharmacy “Iuliu Hatieganu”, 400012 Cluj-Napoca, Romania
Interests: adenylate kinase; enzymatic inhibitors; antibiotic resistance; natural products
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Iuliu Hațieganu University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cluj Napoca, Romania
Interests: computational chemistry; drug discovery; medicinal chemistry
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Iuliu Hațieganu University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cluj Napoca, Romania
Interests: antibiotics discovery; anticancerous drugs discovery; medicinal chemistry; organic synthesis
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

This Special Issue focuses on inhibitors that target bacterial metabolism and are used to explore the metabolic pathways of prokaryotic cells. We aim to analyze natural and synthetic compounds that target the same metabolic pathway via comparative studies.

The increasing prevalence of multi-drug resistant bacterial strains has intensified research efforts into finding new inhibitors to manage human infections, especially in treating nosocomial infections, which particularly affect immunosuppressed individuals. It is particularly pertinent to explore other suitable targets, such as enzymes involved in different metabolic pathways.

Computational tools offer significant progress in screening large numbers of compounds to identify the most suitable ones for further study. The synthesis of new inhibitors can be time-consuming; therefore, carefully selecting potentially effective compounds is vital. Moreover, the differences between eukaryotic and prokaryotic metabolic pathways enable further toxicity studies. Testing inhibitors is a means to demonstrate their efficacy, advancing their use in therapy. In addition, the variety of natural resources across different environments provides an abundance of natural compounds, which can be selected and used alone or in combination to target specific metabolic pathways.  

In this Special Issue, we seek research articles and reviews that present innovative findings
that advance our knowledge of inhibitors of bacterial metabolism.

Dr. Mihaela Ileana Ionescu
Dr. Cristina Nastasă
Prof. Dr. Ovidiu Oniga
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • bacterial metabolism
  • protein kinases
  • therapeutic strategy
  • clinical studies
  • natural inhibitors
  • enzymatic activity
  • drug design
  • structural studies

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop